• Sign In
    My Account
    • Edit Profile
    • Logout
Logo
  • Home
  • How to use
    • Indications
    • Dosage
    • Pen
    • Syringe
    • Storing and handling
    • Safety profile
    • Contraindications
  • Studies
  • Supporting you and your patients
    • For HCPs
    • For your patients
  • Congresses and events

Unlock more
freedom

IMRALDI™. THE ADALIMUMAB FROM BIOGEN.

lNDlCATlONS

DOSlNG lMRALDl™

STORlNG AND
HANDLlNG lMRALDl™

SAFETY PROFlLE

CONTRAlNDlCATlONS

ESTABLlSHlNG
CLlNlCAL EQUlVALENCE

ADMlNlSTRATlON

SUPPORTlNG YOU
AND YOUR PATlENTS

CONGRESSES
& EVENTS

ABOUT BlOGEN

REGlSTER FOR
EXCLUSlVE CONTENT

CONTACT US

  • How to use
  • Indications
  • Pen
  • Syringe
  • Dosage
  • Storing and handling
  • Safety profile
  • Contraindications

Studies

Clinical trials

  • Supporting you and your patients
  • For HCPs
  • For your patients
  • Congresses and events
  • Exclusive Content

Sign up today to our
exclusive content
and stay up to date

 

Register here

biogen.com
Privacy Policy Terms and Conditions Cookies

This site is intended for EU healthcare professionals only.
Biogen - 112924.
Date of preparation: February 2022.

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.
Healthcare professionals are asked to report any suspected adverse reactions.

Dosing Calculator
hidden buttton